Getagraph.com logo
NASDAQ Composite: ( -0.71%) 17 733
S&P 500 Futures
(0.12%) 5 528.00 points
Dow Jones Futures
(0.18%) 39 540 points
Nasdaq Futures
(0.07%) 19 942 points
Oil
(0.39%) $81.86
Gas
(-1.04%) $2.57
Gold
(-0.24%) $2 334.10
Silver
(0.85%) $29.49
Platinum
(-1.03%) $1 003.70
USD/EUR
(-0.50%) $0.929
USD/NOK
(-0.51%) $10.62
USD/GBP
(-0.22%) $0.789
USD/RUB
(1.49%) $87.00

Realtime updates for Sarepta Therapeutics, [0L35.L]

Exchange: London Stock Exchange Sector: Healthcare Industry: Medical - Pharmaceuticals
Last Updated28 Jun 2024 @ 13:55
25% discount on Stockinvest.us - Use code: Podcast

1.37% $ 158.65

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 13:55):
Our systems believe the stock currently is overvalued by -1.25% compare to its pairs and should correct downwards.
Profile picture for Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases...

Stats
Today's Volume 351
Average Volume 424
Market Cap 15.00B
EPS $0.380 ( Q1 | 2024-05-01 )
Next earnings date ( $0 ) 2024-07-30
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -37.02
(Sector) 0
(Industry) 0
ATR14 $1.006 (0.64%)